Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report

June 5, 2025 | Patient involvement, Trial Design, clinical trials, insight, patient engagement 

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Upcoming report announcement

Cuttsy+Cuttsy, the original patient communications agency, in partnership with the International Society for Patient Engagement Professionals (ISPEP), is proud to announce the upcoming release of their latest report, offering a 360-degree view into patient engagement in clinical trials, both at recruitment stage and during their time participating in a trial.

Based on extensive global research with over 700 clinical trial patients, as well as insights from the specialist Cuttsy+Cuttsy team alongside industry leaders, the report provides a comprehensive analysis of patient experiences. It sheds light on their motivations, emotional and psychological responses, effectiveness of support materials, and need for clear communication during clinical trials. By gathering feedback from an international audience, the findings offer actionable strategies to enhance patient satisfaction, trial completion rates, and overall study success on a global stage.

“Too often, the patient voice is acknowledged in theory but overlooked in practice,” said Caroline Benson, Co-Founder of Cuttsy+Cuttsy. “This report is about more than metrics; it’s about truly listening to what patients experience and need. When we design trials around real people, not just protocols, everyone wins.”

Alongside ISPEP’s aim to amplify the patient voice across medicine development, this report exemplifies Cuttsy+Cuttsy’s mission to empower the healthcare industry with data-driven tools that advance patient-centric approaches to clinical research.

Request a copy of the new report.

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience

Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study journey.

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.